Viela Bio Announces Final Results from Phase 1b Trial of VIB7734 in Patients with Cutaneous Lupus Erythematosus

NEXT STORY
Coherus BioSciences Reports Third Quarter 2020 Financial Results
PREV STORY
Inventiva announces the appointment of Dr. Michael Cooreman as Chief Medical Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biocartis Group NV: Eight Idylla(TM) Performance Studies to be Presented at the Association for Molecular Pathology Conference in the US

PRESS RELEASE: 1 November 2018, 07:00 CEST/00:00 CDT Eight Idylla(TM) Performance Studies to be Presented ...

author_avatar
NASDAQ Market News

Ramsay Sante successfully refinanced its syndicated debt

author_avatar
NASDAQ Market News

TRACON Pharmaceuticals Highlights Updated Envafolimab Results in MSI-H/dMMR Colorectal Cancer and Results from Clinical Trial of Opdivo and Yervoy Combination Therapy in Undifferentiated Pleomorphic Sarcoma Conducted by Alliance for Clinical Trials in Oncology

author_avatar
NASDAQ Market News